Literature DB >> 32601136

Cardiac tamponade after superior vena cava stenting.

Kale S Bongers1, Vaiibhav Patel2, Sarah K Gualano2, Richard J Schildhouse3,4.   

Abstract

Superior vena cava (SVC) syndrome results from the blockage of venous blood flow through the SVC, which is caused by either internal obstruction (eg, thrombus) or external compression (eg, thoracic malignancy and infection).1 While thrombus-related SVC syndrome is rising in prevalence, malignancy still accounts for the majority of cases.1 Regardless of cause, SVC syndrome is characterised by facial swelling and plethora, headache and dyspnoea.2 Although venous stenting has become standard of care for treatment of acute SVC syndrome, stent placement presents multiple risks including SVC rupture and cardiac tamponade. In these cases, a high index of suspicion and prompt action are required to avoid an often fatal outcome. Here, we present the case of a patient with cardiac tamponade and subsequent cardiac arrest after SVC stent placement. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  adult intensive care; cardiothoracic surgery; interventional radiology; pericardial disease

Mesh:

Year:  2020        PMID: 32601136      PMCID: PMC7326245          DOI: 10.1136/bcr-2020-234345

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  27 in total

1.  Successful emergency stent implantation for superior vena cava perforation during malignant stenosis venoplasty.

Authors:  Michael Mansour; Alexander Altenburg; Patrick Haage
Journal:  Cardiovasc Intervent Radiol       Date:  2009-05-16       Impact factor: 2.740

2.  Successful treatment of superior vena cava rupture with placement of a covered stent: a report of two cases.

Authors:  Ryan Jean-Baptiste; David M Williams; Joseph J Gemmete
Journal:  Cardiovasc Intervent Radiol       Date:  2011-06       Impact factor: 2.740

3.  A "Train-Track" Technique in Anatomic Reconstruction of SVC Bifurcation Complicated by Cardiac Tamponade: An Introspection.

Authors:  Karunakaravel Karuppasamy; Mohammed Al-Natour; Ram Kishore Gurajala
Journal:  Cardiovasc Intervent Radiol       Date:  2016-12-08       Impact factor: 2.740

4.  Aortic laceration secondary to palmaz stent placement for treatment of superior vena cava syndrome.

Authors:  J Evans; Z Saba; H Rosenfeld; L Thompson; R Williams
Journal:  Catheter Cardiovasc Interv       Date:  2000-02       Impact factor: 2.692

5.  Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years.

Authors:  Teresa S M Tsang; Maurice Enriquez-Sarano; William K Freeman; Marion E Barnes; Lawrence J Sinak; Bernard J Gersh; Kent R Bailey; James B Seward
Journal:  Mayo Clin Proc       Date:  2002-05       Impact factor: 7.616

6.  Fatal pericardial tamponade after Wallstent implantation for malignant superior vena cava syndrome.

Authors:  Matthias Martin; Iris Baumgartner; Martin Kolb; Jürgen Triller; Hans-Peter Dinkel
Journal:  J Endovasc Ther       Date:  2002-10       Impact factor: 3.487

7.  Long-term results of endovascular stent placement in the superior caval venous system.

Authors:  T Smayra; P Otal; V Chabbert; P Chemla; M Romero; F Joffre; H Rousseau
Journal:  Cardiovasc Intervent Radiol       Date:  2001-10-17       Impact factor: 2.740

8.  Acute Pericardial Effusion during Endovascular Intervention for Superior Vena Cava Syndrome: Case Series and Review.

Authors:  Susan K O'Horo; Gregory M Soares; Gregory J Dubel
Journal:  Semin Intervent Radiol       Date:  2007-03       Impact factor: 1.513

9.  Superior vena cava rupture during balloon angioplasty and stent placement to relieve superior vena cava syndrome: a case report.

Authors:  Louis E Samuels; Joseph B Nyzio; John W C Entwistle
Journal:  Heart Surg Forum       Date:  2007       Impact factor: 0.676

10.  Fatal pericardial tamponade after superior vena cava stenting.

Authors:  Marieke J M Ploegmakers; Matthieu J C M Rutten
Journal:  Cardiovasc Intervent Radiol       Date:  2008-10-15       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.